Mohali, Punjab, India :
Nutro Life Science,
(Livo Universal Healthcare Pvt Ltd.), a rapidly growing name in the global
nutraceutical and sports nutrition manufacturing industry, has announced plans
to establish what is poised to be the world’s first fully robotic sports
nutrition manufacturing facility in India. This landmark project reflects the
company’s commitment to innovation, quality, and large-scale manufacturing
excellence.

Currently under
construction in Ludhiana on over one acre of land, the facility is expected to
be operational by December 2026. It is set to redefine manufacturing benchmarks
through enhanced precision, scalability, and hygiene.

One of the most
compelling aspects of the company’s journey is the entrepreneurial story behind
its leadership. Founded in 2015 by brothers Tanishq Dhingra and Tejasvi
Dhingra, who began working at the young ages of 17 and 19 respectively, the
company started with an initial investment of approximately ₹20,000. Over the
past 11 years, it has grown steadily and is now valued at an estimated ₹200–₹250
crores. Their journey reflects resilience, long-term vision, and disciplined
execution, transforming a bootstrap venture into a globally expanding
enterprise.

The upcoming Ludhiana
plant represents a major advancement in India’s nutraceutical manufacturing
ecosystem. Designed with end-to-end robotics and automation across the
production lifecycle, the facility will significantly reduce human
intervention, ensuring higher consistency, improved hygiene standards, and
near-zero manufacturing errors.

Globally, robotic
manufacturing is increasingly becoming the benchmark in pharmaceutical and
nutraceutical production due to its ability to deliver precision at scale. With
this initiative, the company is set to elevate India’s manufacturing standards
to align with global best practices. Once operational, the plant will
substantially increase production capacity, enabling it to meet growing
domestic demand while strengthening its export capabilities.

Under the leadership of
its co-founders, the company has consistently focused on scientific integrity,
high-quality formulations, and operational excellence. This strategic vision is
central to the Ludhiana project, ensuring that the new facility becomes a
benchmark for advanced manufacturing in the industry.

The company operates
through a strategically distributed network, with its primary manufacturing and
operational base in Mohali and its corporate office in Gurugram managing
business development and partnerships. The addition of the Ludhiana facility
will strengthen this ecosystem, creating a robust three-city operational model
that supports efficient production, seamless distribution, and stronger
collaboration with partners.

It specializes
exclusively in sports nutrition and nutraceutical products tailored for athletes,
fitness enthusiasts, and performance-focused consumers. Its portfolio includes
whey protein, plant-based protein, mass gainers, pre-workouts, amino acid
supplements, fat burners, hydration solutions, and ketogenic nutrition
products. All products are developed using high-quality raw materials and
rigorously vetted suppliers to ensure consistency and trust across domestic and
international markets.

A key pillar of the
business model is its end-to-end contract manufacturing and white-label
services. The company provides turnkey solutions including formulation,
sourcing, production, testing, packaging, and logistics. This approach enables
fitness entrepreneurs, gym chains, and established nutrition brands to launch
and scale products without investing in manufacturing infrastructure. The
upcoming robotic facility will further enhance these capabilities through
faster turnaround times, higher production volumes, and improved operational
reliability.

The company operates
under globally recognized certifications such as ISO 9001, GMP, and HACCP,
ensuring strict adherence to quality and safety standards. Comprehensive
quality checks are implemented at every stage, from raw material sourcing to
final packaging. The Ludhiana facility is expected to further elevate these
standards through advanced automation, enhancing process control and minimizing
variability.

With a presence in over
five countries and a client base of more than 500 partners, the company
continues to strengthen its global footprint. Supported by industry experience
and a growing workforce, its expansion is driven by consistent product quality,
regulatory compliance, and reliable supply chain execution. The additional
capacity from the Ludhiana plant is expected to accelerate international growth
and position India as a competitive hub for nutraceutical manufacturing.

With the launch of this
advanced facility, the company has outlined a strong financial and strategic
roadmap. By the end of FY 2027–28, it aims to achieve a valuation of ₹500–₹600
crores. This growth will be driven by increased production capacity, expansion
into international markets, stronger contract manufacturing partnerships, and
enhanced operational efficiency through automation.

Final Strategic
Takeaway

Nutro Life Science is
entering its next growth phase, where:
 • Past 11 years represent foundation
building
 • Next 3–4 years will focus on
aggressive scaling and global positioning

With the robotic plant
acting as a catalyst and a clear vision of achieving a ₹500–₹600 crore valuation
by FY 2027–28, the company is not just expanding its operations, it is
engineering its leadership position in the global sports nutrition industry.

About Nutro Life
Science

Nutro Life Science,  (Livo Universal Healthcare Pvt Ltd.) is a
leading contract manufacturer in the sports nutrition and nutraceutical
industry. Founded in 2015, the company operates with its corporate office in
Gurugram, Haryana, and its primary manufacturing base in Mohali, Punjab. It
specializes in third-party manufacturing and white-label solutions for clients
across multiple international markets. Its upcoming robotic manufacturing
facility in Ludhiana represents a first-of-its-kind innovation in India’s
sports nutrition sector.